TSWM
PFE icon

Tyler-Stone Wealth Management’s Pfizer PFE Stock Holding History

Tyler-Stone Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8
Closed -$1K – 888
2022
Q2 		$1K Hold
8
– – ﹤0.01% 826
2022
Q1 		$1K Hold
8
– – ﹤0.01% 803
2021
Q4 		$4K Buy
+8
New +$396 ﹤0.01% 736

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tyler-Stone Wealth Management's PFE Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Pfizer (PFE) stake by 2.5% in Q2 2025, selling an estimated $39.2K and leaving 64,772 shares worth $1.57M. The position accounts for 0.25% of the portfolio, ranked #77.

Tyler-Stone Wealth Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.18M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Tyler-Stone Wealth Management held 64,772 shares of Pfizer worth $1.57M as of Q2 2025.
  • Tyler-Stone Wealth Management sold 1,681 Pfizer shares in Q2 2025, an estimated $39.2K.
  • Pfizer made up 0.25% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #77 holding.
  • Tyler-Stone Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Tyler-Stone Wealth Management's Pfizer position peaked at $3.18M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.